Scientists found six biomarkers that detect drug-induced kidney injury within 24 hours, allowing faster treatment and safer ...

In patients with heart failure with preserved ejection fraction and obesity, tirzepatide improved clinical outcomes compared ...

Advanced treatments for kidney failure offers patients improved survival rates and quality of life. Discover the options from ...

When the U.S. Food and Drug Administration (FDA) approved rosuvastatin, early reports indicated that it could cause blood ...

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with ...

The institute is now working to eliminate such risks with a $4.9m multidisciplinary drug trial. The drug is used to cool ...

According to the CDC, around 37 million American adults have chronic kidney disease, and millions more are at risk of developing it.

Critical Path Institute® (C-Path) and Boston Medical Center (BMC) published results for six biomarkers that could improve the early and accurate detection of kidney injury, leading to both the ...